EAST RUTHERFORD, N.J., May 29, 2012 /PRNewswire/ -- CCA Industries, Inc. (NYSE MKT: CAW) announced today that its Board of Directors has approved a dividend of $0.07 per share for the second quarter of fiscal 2012, payable to all shareholders of record as of June 8, 2012, and to be paid on July 9, 2012. This will be the Company's thirty-second consecutive dividend. Results for the second quarter ending May 31, 2012 will be announced on or before July 16, 2012. "We are continuing our record of dividends, as management and the Board of Directors remain optimistic regarding the Company's future growth," stated Dunnan D. Edell, President and Chief Executive Officer. CCA Industries, Inc. manufactures and markets health and beauty aids, each under its individual brand name. The products include, principally, "Plus+White" toothpastes and teeth whiteners, "Mega-T" Green Tea diet supplements, "Mega-T" Green Tea gum and mint products, "Bikini Zone" medicated topical and shave gels, " Nutra Nail" nail care treatments, "Gel Perfect" UV free gel color, "Scar Zone" scar treatment products, "Sudden Change" anti-aging skin care products, "Cherry Vanilla" fragrances, "Solar Sense" sun protection products, "Hair Off" hair removal and depilatory products, "Wash 'N Curl" shampoos and conditioners and "Pain Bust RII" an analgesic product. Statements contained in the news release that are not historical facts are forward looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties, which would cause actual results to differ materially form estimated results. Such risks and uncertainties are detailed in the Company's filings with the Securities and Exchange Commission. No assurance can be given that the results in any forward-looking statement will be achieved and actual results could be affected by one or more factors, which could cause them to differ materially. For these statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act.